Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share - Antidilutive Securities (Details)

v3.24.1.u1
Net Loss Per Share - Antidilutive Securities (Details) - shares
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 10,194,371 11,563,536
Options to purchase common stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 1,778,112 3,913,926
Number of shares issuable from ESPP    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 130,113 192,551
Restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 8,286,146 7,457,059